se of intravenous acetylsalicylic acid (‘Aspirin’) as a novel antidote for human paraquat poisoning- can it reduce the 70% mortality rate and oxidative stress?
Phase 2
Completed
- Conditions
- Paraquat self poisoning
- Registration Number
- SLCTR/2009/001
- Lead Sponsor
- Welcome Trust and NHMRC through SACTRC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Paraquat self poisoning presenting within 24 hours and a positive urine dithionite test
Exclusion Criteria
Age under 14 years pregnanacy presenting after 24 hours known aspirin allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method